Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $106.6400 (3.49%) ($100.6700 - $107.0400) on Mon. May. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.33% (three month average) | RSI | 61 | Latest Price | $106.6400(3.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 2.2% a day on average for past five trading days. | Weekly Trend | LGND advances 3.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(53%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -3.165% in a week (0% probabilities). VIXM(-24%) VXX(-16%) UUP(-16%) UNG(-2%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.165% (StdDev 6.33%) | Hourly BBV | 0 () | Intraday Trend | 5.3% | | | |
|
5 Day Moving Average | $102.83(3.71%) | 10 Day Moving Average | $99.79(6.86%) | 20 Day Moving Average | $97.01(9.93%) | To recent high | -1.1% | To recent low | 68.3% | Market Cap | $1.714b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |